Kevin M. Picardat

Array ( [id] => 196146 [patent_doc_number] => 07638151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Grain compositions containing pre-biotic isomalto-oligosaccharides and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 10/798549 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16775 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638151.pdf [firstpage_image] =>[orig_patent_app_number] => 10798549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468008 [patent_doc_number] => 20040198957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Method for removing endotoxins from protein solutions' [patent_app_type] => new [patent_app_number] => 10/488161 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5292 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198957.pdf [firstpage_image] =>[orig_patent_app_number] => 10488161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275649 [patent_doc_number] => 20040235100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Renilla reniformis green fluorescent protein and mutants thereof' [patent_app_type] => new [patent_app_number] => 10/786425 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20316 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235100.pdf [firstpage_image] =>[orig_patent_app_number] => 10786425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434031 [patent_doc_number] => 20040266674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Lp mammalian proteins; related reagents' [patent_app_type] => new [patent_app_number] => 10/487462 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86317 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266674.pdf [firstpage_image] =>[orig_patent_app_number] => 10487462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4431187 [patent_doc_number] => 07968103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components' [patent_app_type] => utility [patent_app_number] => 10/545500 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 39086 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968103.pdf [firstpage_image] =>[orig_patent_app_number] => 10545500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083801 [patent_doc_number] => 20050049181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Synergistic antimicrobial compositions and methods of inhibiting biofilm formation' [patent_app_type] => utility [patent_app_number] => 10/781464 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8198 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049181.pdf [firstpage_image] =>[orig_patent_app_number] => 10781464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288000 [patent_doc_number] => 20040147431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Erythropoietin composition' [patent_app_type] => new [patent_app_number] => 10/780297 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15296 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147431.pdf [firstpage_image] =>[orig_patent_app_number] => 10780297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880059 [patent_doc_number] => 07354905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Prodrugs of thrombin inhibitors' [patent_app_type] => utility [patent_app_number] => 10/776245 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21859 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/354/07354905.pdf [firstpage_image] =>[orig_patent_app_number] => 10776245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624314 [patent_doc_number] => 08003610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Bradykinin B2 receptor antagonist peptide from amphibian skin' [patent_app_type] => utility [patent_app_number] => 10/544946 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 13785 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003610.pdf [firstpage_image] =>[orig_patent_app_number] => 10544946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7317593 [patent_doc_number] => 20040224361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Biosensor and use thereof to identify therapeutic drug molecules and molecules binding orphan receptors' [patent_app_type] => new [patent_app_number] => 10/771897 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 14748 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224361.pdf [firstpage_image] =>[orig_patent_app_number] => 10771897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348259 [patent_doc_number] => 20040248212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Knockout identification of target-specific sites in peptides' [patent_app_type] => new [patent_app_number] => 10/769695 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19621 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248212.pdf [firstpage_image] =>[orig_patent_app_number] => 10769695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930803 [patent_doc_number] => 20050281837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Immunologically active peptides with altered toxicity useful for the preparation of antipertussis vaccine' [patent_app_type] => utility [patent_app_number] => 10/766560 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6634 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281837.pdf [firstpage_image] =>[orig_patent_app_number] => 10766560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675291 [patent_doc_number] => 20040126827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Novel proteins within the type E botulinum neurotoxin complex' [patent_app_type] => new [patent_app_number] => 10/766283 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8084 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126827.pdf [firstpage_image] =>[orig_patent_app_number] => 10766283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32679 [patent_doc_number] => 07790678 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-09-07 [patent_title] => 'Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use' [patent_app_type] => utility [patent_app_number] => 10/765664 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13747 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790678.pdf [firstpage_image] =>[orig_patent_app_number] => 10765664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329341 [patent_doc_number] => 20040139498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Fatty acid elongase 3-ketoacyl CoA synthase polypeptides' [patent_app_type] => new [patent_app_number] => 10/758524 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 10474 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20040139498.pdf [firstpage_image] =>[orig_patent_app_number] => 10758524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329342 [patent_doc_number] => 20040139499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Cytochrome P450 dependent enzyme associated with the synthesis of the epoxy group of vernolic acid' [patent_app_type] => new [patent_app_number] => 10/759813 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17692 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20040139499.pdf [firstpage_image] =>[orig_patent_app_number] => 10759813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252324 [patent_doc_number] => 20040259192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Method for cleaving the human growth hormone gh' [patent_app_type] => new [patent_app_number] => 10/472472 [patent_app_country] => US [patent_app_date] => 2004-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6367 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259192.pdf [firstpage_image] =>[orig_patent_app_number] => 10472472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211651 [patent_doc_number] => 20050054024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Fluorescent assays for protein kinases' [patent_app_type] => utility [patent_app_number] => 10/755086 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26712 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054024.pdf [firstpage_image] =>[orig_patent_app_number] => 10755086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851142 [patent_doc_number] => 20060234333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Method for producing carotenoids or their precursors using genetically modified organisms of the blakeslea genus, carotenoids or their precursors produced by said method and use thereof' [patent_app_type] => utility [patent_app_number] => 10/541750 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22730 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234333.pdf [firstpage_image] =>[orig_patent_app_number] => 10541750 [rel_patent_id] =>[rel_patent_doc_number] =>)